C4 Therapeutics shares owned by UBS Group
Historical chart of UBS Group investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $137k | 62k | 2.22 |
| 2025-06-30 | $818k | 572k | 1.43 |
| 2025-03-31 | $1.4M | 873k | 1.60 |
| 2024-12-31 | $2.7M | 758k | 3.60 |
| 2024-09-30 | $1.9M | 334k | 5.70 |
| 2024-06-30 | $1.9M | 404k | 4.62 |
| 2024-03-31 | $5.7M | 697k | 8.17 |
| 2023-12-31 | $1.6M | 278k | 5.65 |
| 2023-09-30 | $598k | 322k | 1.86 |
| 2023-06-30 | $742k | 270k | 2.75 |
| 2023-03-31 | $511k | 163k | 3.14 |
| 2022-12-31 | $1.6M | 270k | 5.90 |
| 2022-09-30 | $2.8M | 317k | 8.73 |
| 2022-06-30 | $2.8M | 377k | 7.53 |
| 2022-03-31 | $8.0M | 330k | 24.25 |
| 2021-12-31 | $11M | 343k | 32.20 |
| 2021-09-30 | $19M | 417k | 44.68 |
| 2021-06-30 | $15M | 401k | 37.87 |
| 2021-03-31 | $9.7M | 262k | 36.99 |
| 2020-12-31 | $3.3M | 101k | 32.93 |